This peak includes candidate genes, such as SERPINA1 and SERPINA2 (serine-peptidase inhibitor, clade A, members 1 and 2), which were previously implicated in a GWAS for substance abuse vulnerability [106]. This evidence concerns the gene SERPINA1 and substance abuse.